All Pharma News
Setsuro Tech gets access to ERS Genomics’ CRISPR/Cas9 patent portfolio for Japan

Setsuro Tech gets access to ERS Genomics’ CRISPR/Cas9 patent portfolio for Japan
BIOSPECTRUMASIA
10 Mar 2021
Share Share
Sumitomo Chemical accelerates next-gen biz utilizing synthetic biology

Sumitomo Chemical accelerates next-gen biz utilizing synthetic biology
BIOSPECTRUMASIA
16 Nov 2020
Share Share
Sumitomo subsidiary flashes new way of treating schizophrenia in PhII trial

Sumitomo subsidiary flashes new way of treating schizophrenia in PhII trial
Jason Mast COM
16 Apr 2020
Share Share
Poxel, Sumitomo Pharma Announce +Ve Phase 3 Results from TIMES 2 Trial

Poxel, Sumitomo Pharma Announce +Ve Phase 3 Results from TIMES 2 Trial
BUSINESSWIRE
20 Dec 2019
Share Share
Rentschler Biopharma reveals push for expanding operation in Japan

Rentschler Biopharma reveals push for expanding operation in Japan
Murielle Gonzalez MANUFACTURING
05 Oct 2019
Share Share
Sumitomo Corporation Acquires Ownership Of Paris Distributor SACI-CFPA; Expands Global Footprint In Personal Care Market

Sumitomo Corporation Acquires Ownership Of Paris Distributor SACI-CFPA; Expands Global Footprint In Personal Care Market
PR NEWSWIRE
01 Apr 2019
Share Share
Sumitomo (SHI) Demag syncs ejector with medical mould movement

Sumitomo (SHI) Demag syncs ejector with medical mould movement
MANUFACTURING CHEMIST
29 Nov 2018
Share Share
Japan permits Toray’s Additional Indication of Pruritus Treatment Drug

Japan permits Toray’s Additional Indication of Pruritus Treatment Drug
Biospectrum Bureau BIOSPECTRUM ASIA
22 May 2015
Share Share
Takeda, Orexigen end CV study for obesity drug Contrave

Takeda, Orexigen end CV study for obesity drug Contrave
Ej Lane FIERCE PHARMA ASIA
13 May 2015
Share Share
Sumitomo Dainippon says Latuda for schizophrenia in Japan misses PhIII aims

Sumitomo Dainippon says Latuda for schizophrenia in Japan misses PhIII aims
Ej Lane FIERCE PHARMA ASIA
27 Apr 2015
Share Share